| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 112,078 shares worth roughly $7.8M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), PTCT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $77.68M | -5,000 | |
| CEO | 383.9K | $26.32M | - | |
| VP | 105.3K | $6.76M | -2,265 | |
| CFO | 84.0K | $6.75M | - | |
| VP | 79.1K | $5.38M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Pauwels Eric61 | Chief Business Officer | Sale+OE10b5-1 | 43,492 | $75.40 | $3,279,275.05 | -38.2% | -10.2% | - | |
| Dec 3, 2025 | Reeve Emma73 | Director | Sale+OE10b5-1 | 733 | $78.62 | $57,628.46 | -9.9% | -15.1% | - | |
| Dec 2, 2025 | Klein Matthew B.53 | Chief Executive Officer | Sell10b5-1 | 3,428 | $79.07 | $271,051.96 | -1.0% | -15.5% | - | |
| Nov 25, 2025 | Almstead Neil Gregory55 | Chief Technical Ops Officer | Sale+OE10b5-1 | 71,928 | $83.44 | $6,001,932.05 | -41.7% | -15.0% | - | |
| Nov 25, 2025 | Jacobson Allan Steven53 | Director | Sale+OE10b5-1 | 26,000 | $82.00 | $2,132,018.42 | -59.8% | -15.0% | - | |
| Nov 24, 2025 | Almstead Neil Gregory55 | Chief Technical Ops Officer | Sale+OE10b5-1 | 35,572 | $80.18 | $2,852,030.56 | -26.1% | -11.7% | - | |
| Nov 21, 2025 | Reeve Emma73 | Director | Sale+OE10b5-1 | 10,000 | $79.50 | $795,000.00 | -60.0% | -10.9% | - | |
| Nov 17, 2025 | Boulding Mark Elliott56 | Executive VP and CLO | Sale+OE10b5-1 | 2,812 | $75.99 | $213,686.89 | -2.6% | -8.5% | - | |
| Nov 12, 2025 | Reeve Emma73 | Director | Sale+OE10b5-1 | 7,333 | $74.50 | $546,308.50 | -52.4% | -3.7% | - | |
| Oct 30, 2025 | Reeve Emma73 | Director | Sale+OE10b5-1 | 15,666 | $69.50 | $1,088,787.00 | -70.2% | +11.0% | -5.4% |